In the acute myocardial infarction (AMI) subgroup, we observed a significant association of CYP2C19 phenotypes and 1-year MACCE-free survival (NM + RM: 94.6% vs. IM: 91.2% vs. PM: 77.5%, p = 0.007, Figure 3). The gene discussed is CYP2C19; the disease is acute myocardial infarction.